Content resistin plasma and nonspecific inflammation markers in patients with type 2 diabetes compensation from different diseases
Saved in:
| Date: | 2015 |
|---|---|
| Main Author: | A. M. Urbanovych |
| Format: | Article |
| Language: | English |
| Published: |
2015
|
| Series: | Actual problems of transport medicine: environment, occupational health, pathology |
| Online Access: | http://jnas.nbuv.gov.ua/article/UJRN-0000594130 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Library portal of National Academy of Sciences of Ukraine | LibNAS |
Institution
Library portal of National Academy of Sciences of Ukraine | LibNASSimilar Items
Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease
by: M. D. Tronko, et al.
Published: (2021)
by: M. D. Tronko, et al.
Published: (2021)
Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease
by: Tronko, M.D., et al.
Published: (2021)
by: Tronko, M.D., et al.
Published: (2021)
The blood leptin content and the activity of the zonal system response in patients with diabetes mellitus type 2 with different body weight and disease duration
by: B. M. Mankovskyi, et al.
Published: (2014)
by: B. M. Mankovskyi, et al.
Published: (2014)
Cardiovascular disease among patients with type 2 diabetes: Role of homocysteine as an inflammatory marker
by: A. Sahu, et al.
Published: (2016)
by: A. Sahu, et al.
Published: (2016)
Leptin and resistin levels in serum of patients with hematologic malignancies: correlation with clinical characteristic
by: Pamuk, G.E., et al.
Published: (2006)
by: Pamuk, G.E., et al.
Published: (2006)
Apolipoprotein B and oxLDL levels in plasma of patients with diabetes, cardiovascular disease, and COVID-19
by: Tronko, M.D., et al.
Published: (2021)
by: Tronko, M.D., et al.
Published: (2021)
Cerebrovascular insufficiency and diabetic encephalopathy in patients with type 2 diabetes mellitus
by: E. L. Tovazhnjanskaja, et al.
Published: (2014)
by: E. L. Tovazhnjanskaja, et al.
Published: (2014)
Cerebrovascular insufficiency and diabetic encephalopathy in patients with type 2 diabetes mellitus
by: Tovazhnyanska, E.L., et al.
Published: (2014)
by: Tovazhnyanska, E.L., et al.
Published: (2014)
Echographic markers of vascular and cardiac disorders in patients with arterial hypertension and arterial hypertension associated with type 2 diabetes mellitus
by: Ya. K. Radzishevska
Published: (2015)
by: Ya. K. Radzishevska
Published: (2015)
Bradykinin content in the blood of patients with COVID-19 and diabetes mellitus
by: M. D. Tronko, et al.
Published: (2024)
by: M. D. Tronko, et al.
Published: (2024)
The role of resistin in the genesis of metabolic disorders in pathological pregnancy
by: S. O. Ostafiichuk
Published: (2019)
by: S. O. Ostafiichuk
Published: (2019)
Effects of COVID-19, diabetes mellitus, and cardiovascular diseases on insulinre ceptor substrate-1 amount in the blood plasma of patients
by: M. D. Tronko, et al.
Published: (2021)
by: M. D. Tronko, et al.
Published: (2021)
Effects of COVID-19, diabetes mellitus, and cardiovascular diseases on insulin receptor substrate-1 amount in the blood plasma of patients
by: Tronko, M.D., et al.
Published: (2021)
by: Tronko, M.D., et al.
Published: (2021)
Plasma apolipoproteins A1/B and oxLDL levels in patients with COVID-19 as possible markers of the disease
by: V. V. Pushkarov, et al.
Published: (2021)
by: V. V. Pushkarov, et al.
Published: (2021)
Features of pleural cavity drainage in patients with acute nonspecific pleural empyema
by: D. V. Minukhin, et al.
Published: (2020)
by: D. V. Minukhin, et al.
Published: (2020)
Relationship between daily blood pressure profile and a marker of chronic systemic inflammation in patients with stage 2 essential hypertension with microalbuminuria
by: E. M. Vlasenko
Published: (2015)
by: E. M. Vlasenko
Published: (2015)
Іnfluence of excessive body mass on formation of systemic proinflammatory cytokine potential in patients with purulent-destructive forms of chronic nonspecific pulmonary diseases
by: Mindrul, M.A.
Published: (2013)
by: Mindrul, M.A.
Published: (2013)
Vitamin D in the complex treatment of diabetes type 2 patients
by: A. S. Yefimov, et al.
Published: (2014)
by: A. S. Yefimov, et al.
Published: (2014)
Specificity of perception and emotions in patients with schizophrenia with diabetes mellitus type 2
by: Ye. V. Opria
Published: (2018)
by: Ye. V. Opria
Published: (2018)
Insulin resistance indexes in patients with ischemic cardiac disease without diabetes mellitus during statine treatment
by: O. Bondarenko, et al.
Published: (2016)
by: O. Bondarenko, et al.
Published: (2016)
Functional state of metabolic syndrome markers in traumatic disease in patients with increased body mass index
by: V. V. Kucheriavchenko, et al.
Published: (2019)
by: V. V. Kucheriavchenko, et al.
Published: (2019)
Overall haemostasis potential of the blood plasma and its relation to some molecular markers of the hemostasis system in patients with chronic renal disease of stage VD
by: B. G. Storozhuk, et al.
Published: (2018)
by: B. G. Storozhuk, et al.
Published: (2018)
Comparative analysis of epigenetic markers in plasma and tissue of patients with colorectal cancer
by: Kondratov, A.G., et al.
Published: (2014)
by: Kondratov, A.G., et al.
Published: (2014)
Comparative analysis of epigenetic markers in plasma and tissue of patients with colorectal cancer
by: A. G. Kondratov, et al.
Published: (2014)
by: A. G. Kondratov, et al.
Published: (2014)
The effect of quercetin on oxidative stress markers and mitochondrial permeability transition in the heart of rats with type 2 diabetes
by: N. I. Gorbenko, et al.
Published: (2019)
by: N. I. Gorbenko, et al.
Published: (2019)
The use of phosphodiesterase type 5 inhibitors in patients with type 2 diabetes mellitus and erectile dysfunction
by: Ye. Luchytskyi
Published: (2018)
by: Ye. Luchytskyi
Published: (2018)
Method of diagnosis nonalcoholic fatty liver in patients with type 2 diabetes mellitus
by: K. Kvit, et al.
Published: (2017)
by: K. Kvit, et al.
Published: (2017)
The role of apoptosis in the combined course of chronic obstructive pulmonary disease and type 2 diabetes mellitus
by: N. K. Sukhonos
Published: (2017)
by: N. K. Sukhonos
Published: (2017)
determination of the inflammation cellular mechanisms effect on the development of anemia in patients with pulmonary tuberculosis
by: O. O. Hovardovska
Published: (2019)
by: O. O. Hovardovska
Published: (2019)
Glycemic control in prevention of cardiovascular diseases in diabetes mellitus
by: A. N. Korzh
Published: (2019)
by: A. N. Korzh
Published: (2019)
Effect of cryopreserved fetal nerve cells on markers of immune inflammation of brain tissue under development of ischemic stroke
by: D. V. Lebedinets, et al.
Published: (2010)
by: D. V. Lebedinets, et al.
Published: (2010)
Sortylin influence on the indicators of carbohydrate metabolism at combination of coronary artery disease and type 2 diabetes mellitus
by: A. O. Sypalo
Published: (2017)
by: A. O. Sypalo
Published: (2017)
Q192R polymorphism of PON-1 gene in type 2 diabetic patients
by: Ju. Gorshunskaja, et al.
Published: (2011)
by: Ju. Gorshunskaja, et al.
Published: (2011)
Metabolism features of haptoglobin as inflammation acute phase protein in patients with chronic HCV infection
by: K. V. Yurko, et al.
Published: (2020)
by: K. V. Yurko, et al.
Published: (2020)
Characteristics of Endothelial dysfunction in patients with Diabetes mellitus
by: A. S. Kuznetsova, et al.
Published: (2018)
by: A. S. Kuznetsova, et al.
Published: (2018)
Intra-abdominal hypertension in patients with diabetic ketoacidosis
by: V. Y. Lysenko, et al.
Published: (2014)
by: V. Y. Lysenko, et al.
Published: (2014)
Dynamics of IL-8 level and TGF-β1 of active form in blood serum under influence of excessive body mass in patients with purulent-destructive forms of chronic nonspecific pulmonary diseases
by: Mindrul, M.A.
Published: (2013)
by: Mindrul, M.A.
Published: (2013)
Effects of trimethylamine-n-oxide inhibitor in combination with anticholinesterase in patients with type 2 diabetes mellitus
by: O. Kikhtiak, et al.
Published: (2018)
by: O. Kikhtiak, et al.
Published: (2018)
Optimization of treatment of patients with acute cerebrovascular accident and type 2 diabetes mellitus in the stage of decompensation
by: Yu. I. Rzhevska, et al.
Published: (2020)
by: Yu. I. Rzhevska, et al.
Published: (2020)
Levels of malondialdehyde and magnesium and the activity of catalase and glutathione reductase as markers of oxidative stress in the erythrocytes of patients with Ischemic Heart Disease
by: Chachoua, I., et al.
Published: (2010)
by: Chachoua, I., et al.
Published: (2010)
Similar Items
-
Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease
by: M. D. Tronko, et al.
Published: (2021) -
Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease
by: Tronko, M.D., et al.
Published: (2021) -
The blood leptin content and the activity of the zonal system response in patients with diabetes mellitus type 2 with different body weight and disease duration
by: B. M. Mankovskyi, et al.
Published: (2014) -
Cardiovascular disease among patients with type 2 diabetes: Role of homocysteine as an inflammatory marker
by: A. Sahu, et al.
Published: (2016) -
Leptin and resistin levels in serum of patients with hematologic malignancies: correlation with clinical characteristic
by: Pamuk, G.E., et al.
Published: (2006)